Company profile · sample from DESK
Eli Lilly: revenue, profit and key figures
Eli Lilly is based in the United States and was founded in 1875. In fiscal year 2025 the company reported revenue of $65.2 billion and net income of $20.6 billion (annual report filed with the SEC).
Revenue
$65.2 billion
Fiscal year 2025
20072025
Net income
$20.6 billion
Fiscal year 2025
20072025
Reported annual figures
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue $ bn | 21.5 | 22.3 | 24.5 | 28.3 | 28.5 | 34.1 | 45.0 | 65.2 |
| Net income $ bn | 3.2 | 8.3 | 6.2 | 5.6 | 6.2 | 5.2 | 10.6 | 20.6 |
| Research and development $ bn | 5.1 | 5.6 | 6.0 | 6.9 | 7.2 | — | — | — |
The company
| Based in | United States |
|---|---|
| Founded | 1875 |
| Founders | Eli Lilly |
| Chief executive | David A. Ricks |
| Exchange | New York Stock Exchange (LLY) |
| Employees | 50,000 (2025) |
Source
Annual figures: U.S. Securities and Exchange Commission, EDGAR (the company’s XBRL filings, public domain) – filings at the SEC. The company’s fiscal years, in US dollars, as reported. Company details: Wikidata (CC0). No share price, no valuation, no recommendation.
This is one page of many.
- DESK keeps pages like this for thousands of companies – with quarterly figures, the balance sheet, regulatory filings, locations and supply relationships.
- Every number traces back to its filing.
- Plus the Macro Terminal with more than 900 indicators per country and a weekly report.
Also open to read: Countries in figures · Strait of Hormuz in numbers · Weekly report archive
DESK is a research tool and not investment advice. Page generated: 2026-10-16.